tiprankstipranks
SpyGlass Pharma (SGP)
NASDAQ:SGP
US Market
SGP
SpyGlass Pharma
RESEARCH TOOLSreports
Want to see SGP full AI Analyst Report?

SpyGlass Pharma (SGP) Stock Forecast & Price Target

13 Followers
See the Price Targets and Ratings of:

SGP Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
SpyGlass
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SGP Stock 12 Month Forecast

Average Price Target

$45.00
▲(80.43% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for SpyGlass Pharma in the last 3 months. The average price target is $45.00 with a high forecast of $62.00 and a low forecast of $37.00. The average price target represents a 80.43% change from the last price of $24.94.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"22":"$22","63":"$63","32.25":"$32.3","42.5":"$42.5","52.75":"$52.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$62.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$45.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$37.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[22,32.25,42.5,52.75,63],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.98,26.904615384615383,29.82923076923077,32.753846153846155,35.678461538461534,38.60307692307692,41.527692307692305,44.452307692307684,47.37692307692308,50.301538461538456,53.22615384615384,56.15076923076923,59.07538461538461,{"y":62,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.98,25.596923076923076,27.213846153846156,28.83076923076923,30.447692307692307,32.06461538461539,33.681538461538466,35.29846153846154,36.91538461538462,38.5323076923077,40.14923076923077,41.76615384615384,43.38307692307693,{"y":45,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.98,24.981538461538463,25.983076923076922,26.984615384615385,27.986153846153847,28.987692307692306,29.98923076923077,30.99076923076923,31.99230769230769,32.99384615384615,33.995384615384616,34.996923076923075,35.99846153846154,{"y":37,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.4,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.4,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.73,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.44,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.98,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$62.00Average Price Target$45.00Lowest Price Target$37.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on SGP
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
$42
Buy
68.40%
Upside
Reiterated
05/15/26
SpyGlass Pharma (SGP) Receives a Buy from Stifel Nicolaus
H.C. Wainwright Analyst forecast on SGP
Yi Chen
H.C. Wainwright
H.C. Wainwright
$37
Buy
48.36%
Upside
Reiterated
03/30/26
Analysts Offer Insights on NA Companies: SpyGlass Pharma (Nasdaq: SGP) and Ottobock SE & Co. KGaA (Other OTC: OBCKF)
Jefferies Analyst forecast on SGP
Dennis Ding
Jefferies
Jefferies
$62
Buy
148.60%
Upside
Reiterated
03/27/26
Analysts Offer Insights on NA Companies: BitGo Holdings, Inc. Class A (NYSE: BTGO) and SpyGlass Pharma (Nasdaq: SGP)
Citi Analyst forecast on SGP
Yigal Nochomovitz
Citi
Citi
$42
Buy
68.40%
Upside
Reiterated
03/09/26
De‑Risking Milestone and Pipeline Catalysts Underpin High‑Risk Buy on SpyGlass Pharma
Leerink Partners Analyst forecast on SGP
Marc Goodman
Leerink Partners
Leerink Partners
$42
Buy
68.40%
Upside
Initiated
03/03/26
SpyGlass Pharma initiated with an Outperform at LeerinkSpyGlass Pharma initiated with an Outperform at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on SGP
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
$42
Buy
68.40%
Upside
Reiterated
05/15/26
SpyGlass Pharma (SGP) Receives a Buy from Stifel Nicolaus
H.C. Wainwright Analyst forecast on SGP
Yi Chen
H.C. Wainwright
H.C. Wainwright
$37
Buy
48.36%
Upside
Reiterated
03/30/26
Analysts Offer Insights on NA Companies: SpyGlass Pharma (Nasdaq: SGP) and Ottobock SE & Co. KGaA (Other OTC: OBCKF)
Jefferies Analyst forecast on SGP
Dennis Ding
Jefferies
Jefferies
$62
Buy
148.60%
Upside
Reiterated
03/27/26
Analysts Offer Insights on NA Companies: BitGo Holdings, Inc. Class A (NYSE: BTGO) and SpyGlass Pharma (Nasdaq: SGP)
Citi Analyst forecast on SGP
Yigal Nochomovitz
Citi
Citi
$42
Buy
68.40%
Upside
Reiterated
03/09/26
De‑Risking Milestone and Pipeline Catalysts Underpin High‑Risk Buy on SpyGlass Pharma
Leerink Partners Analyst forecast on SGP
Marc Goodman
Leerink Partners
Leerink Partners
$42
Buy
68.40%
Upside
Initiated
03/03/26
SpyGlass Pharma initiated with an Outperform at LeerinkSpyGlass Pharma initiated with an Outperform at Leerink
Stocks with the Highest Top Analyst Consensus in the General Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering SpyGlass Pharma

3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.00%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -9.00% per trade.
1 Year
Yigal NochomovitzCiti
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.00%
Copying Yigal Nochomovitz's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.00% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.00%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SGP Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
8
8
9
Buy
0
0
1
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
9
9
10
In the current month, SGP has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SGP average Analyst price target in the past 3 months is 45.00.
Each month's total comprises the sum of three months' worth of ratings.

SGP Financial Forecast

SGP Earnings Forecast

Next quarter’s earnings estimate for SGP is -$0.50 with a range of -$0.92 to -$0.23. The previous quarter’s EPS was -$0.69. SGP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SGP has its overall industry.
Next quarter’s earnings estimate for SGP is -$0.50 with a range of -$0.92 to -$0.23. The previous quarter’s EPS was -$0.69. SGP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SGP has its overall industry.
No data currently available

SGP Sales Forecast

Next quarter’s sales forecast for SGP is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SGP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SGP has its overall industry.
Next quarter’s sales forecast for SGP is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SGP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SGP has its overall industry.

SGP Stock Forecast FAQ

What is SGP’s average 12-month price target, according to analysts?
Based on analyst ratings, SpyGlass Pharma’s 12-month average price target is 45.00.
    What is SGP’s upside potential, based on the analysts’ average price target?
    SpyGlass Pharma has 80.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SGP a Buy, Sell or Hold?
          SpyGlass Pharma has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is SpyGlass Pharma’s price target?
            The average price target for SpyGlass Pharma is 45.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $62.00 ,the lowest forecast is $37.00. The average price target represents 80.43% Increase from the current price of $24.94.
              What do analysts say about SpyGlass Pharma?
              SpyGlass Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of SGP?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.